Latest Asx Announcements News

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ notice attempting to terminate their merger agreement, setting the stage for a potential courtroom showdown over the disputed deal.

Dominion Income Trust 1 (ASX – DN1) has announced a $45 million placement at $101 per unit, aiming to enhance fund diversification and liquidity without impacting net asset value.

Challenger Gold Limited has voluntarily suspended its ASX trading pending a significant capital raising announcement, signaling potential strategic moves ahead.

Tasmea Limited has announced a fully franked special dividend of AUD 0.12 per share, payable on 30 June 2025, alongside a Dividend Reinvestment Plan offering a 5% discount on new shares.

Savannah Goldfields has announced a promising new gold Exploration Target at its Big Reef Deposit within the Georgetown Project, potentially extending its resource base and supporting imminent mining plans.

Autosports Group has inked a $350 million syndicated revolving credit facility, streamlining its capital structure and boosting financial flexibility to support future expansion.

Evolution Energy Minerals has landed a US$2 million convertible note commitment from major shareholder ARCH PCC EM SRF to support its Kudu Graphite subsidiary, aiming to accelerate development of the Chilalo Graphite Project.

Horizon Minerals has acknowledged an unintentional breach of ASX Listing Rule 15.7 after sharing details of a $30 million placement with the media before the official market announcement.

Pacgold Limited has raised $5.6 million through a two-tranche placement to accelerate drilling and exploration at its Alice River Gold Project in North Queensland, signaling strong investor confidence.

Wellnex Life Limited’s shares have been suspended from trading on the ASX pending a response to regulatory queries, stirring investor uncertainty.

Prescient Therapeutics has reached a pivotal milestone by dosing the first patient in its Phase 2a clinical trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma (CTCL), aiming to evaluate safety and efficacy across multiple international sites.

Wisr Limited has inked a $267 million loan funding warehouse facility led by Barclays, boosting its capacity to expand personal and secured vehicle loans. This move enhances Wisr’s funding flexibility and cost efficiency as it pursues aggressive growth.